CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8200
-0.0200 (-2.38%)
Jan 21, 2026, 4:08 PM HKT
78.26%
Market Cap7.88B
Revenue (ttm)5.49B
Net Income (ttm)-278.39M
Shares Out9.61B
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,164,040
Average Volume5,648,403
Open0.8300
Previous Close0.8400
Day's Range0.8200 - 0.8400
52-Week Range0.4350 - 1.1000
Beta0.21
RSI35.95
Earnings DateMar 18, 2026

About HKG:0775

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines.... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 2,033
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0775
Full Company Profile

Financial Performance

Financial Statements

News

CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs

CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech...

3 months ago - South China Morning Post

TransCode Acquires Polynoma From CK Life Sciences

(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage candi...

3 months ago - Nasdaq

CK Life’s new CEO counts on Big Pharma experience to boost new drug success, earnings

Lance Yuen spent two decades at Bristol-Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.

1 year ago - South China Morning Post